Especially the metastatic spread of PCa was shown to depend on a gain in epithelial CAV1, and SRC-family kinase inhibitor treatments including PP2 and dasatinib efficiently reduced the metastatic features together with an accompanied reduction in CAV1 Tyr14 phosphorylation (37). This evidence concerns the gene CAV1 and posterior cortical atrophy.